Who
Tage Honore
Director
Company insider
Files Form 4 as: Director, Vanda Pharmaceuticals.
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $482K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 15 Mar 2023
- Last trade
- 4 Jun 2026
- Last filed
- 8 Jun 2026
Companies traded
Activity over time
1 Feb – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Jun 2026filed 8 Jun 2026 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —41,600 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —41,600 at $0.00 | filing |
| 23 Feb 2026filed 24 Feb 2026 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $241K30,000 at $8.03 | filing |
| 23 Feb 2026filed 24 Feb 2026 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $241K30,000 at $8.03 | filing |
| 5 Jun 2025filed 9 Jun 2025 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —59,225 at $0.00 | filing |
| 17 May 2024filed 21 May 2024 | VNDA Vanda Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —37,578 at $0.00 | filing |
| 17 May 2024filed 21 May 2024 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —20,529 at $0.00 | filing |
| 8 Jun 2023filed 12 Jun 2023 | VNDA Vanda Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —33,960 at $0.00 | filing |
| 8 Jun 2023filed 12 Jun 2023 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —17,307 at $0.00 | filing |
| 15 Mar 2023filed 17 Mar 2023 | VNDA Vanda Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —51,276 at $0.00 | filing |
| 15 Mar 2023filed 17 Mar 2023 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —26,408 at $0.00 | filing |
News
Vanda Pharmaceuticals Provides Update on VQW-765 Clinical Development ProgramVNDA · prnewswire.com · 14 Oct 2026
0 headlines in the last 90 days name Tage Honore; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.